Zydus signs a non-exclusive licensing agreement with Gilead Sciences Inc. Featured June 12, 2020 Zydus Cadila, an innovation-driven, global healthcare company today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences…
Zydus Cadila receives final approval from USFDA for Atazanavir Capsules Press Release June 5, 2020 MUMBAI: Zydus Cadila has received final approval from the USFDA to market Atazanavir Capsules (US RLD: Reyataz™ Capsules) in the…
